International Journal of Epilepsy 2015; 02(02): 072-077
DOI: 10.1016/j.ijep.2015.09.001
Original Article
Thieme Medical and Scientific Publishers Private Ltd.

Time to treatment predicts seizure outcome in a high-treatment gap epilepsy population

Michael B. Fawale
a   Neurology Unit, Department of Medicine, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
,
Mayowa O. Owolabi
b   Neurology Unit, Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria
,
Adekunle F. Mustapha
c   Neurology Unit, Department of Medicine, College of Health Sciences, Ladoke Akintola University of Technology, Osogbo, Nigeria
,
Morenikeji A. Komolafe
a   Neurology Unit, Department of Medicine, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
,
Ogunniyi Adesola
c   Neurology Unit, Department of Medicine, College of Health Sciences, Ladoke Akintola University of Technology, Osogbo, Nigeria
› Author Affiliations

Subject Editor:
Further Information

Publication History

Received: 14 January 2015

Accepted: 10 September 2015

Publication Date:
06 May 2018 (online)

Abstract

Objectives To investigate the relationship between time to antiepileptic drug (AED) treatment (TTT) and seizure outcome in a high treatment gap sub-Sahara African setting.

Methods Clinical and demographic characteristics of 72 adults with epilepsy aged 18–75 years were obtained. We estimated TTT as the difference between the duration of epilepsy and the duration of treatment. Indices of clinical outcome including seizure severity and 6-month disease remission were documented. The effects of TTT and other clinical and demographic characteristics on clinical outcomes were tested using bivariate and logistic regression analyses.

Results Forty (55.6%) of the participants initiated treatment within 5 years of seizure onset (TTT ≤ 5 years) while 32 (44.4%) initiated treatment after 5 years (TTT > 5 years). There was moderate to strong correlation between TTT and age of onset (p = .009), age at treatment initiation (p = .026), duration of epilepsy (p = .000), and seizure severity (p = .020). The TTT > 5 years group had an earlier mean age of onset (p = .015) and higher seizure severity score (p = .001) and were less likely to be in 6-month disease remission (p = .014). Time to treatment ≤5 years was the only independent predictor of lesser seizure severity (OR = 0.163, 95% CI = 0.041–0.649) and better 6-month remission (OR = 0.154, 95% CI = 0.031–0.770) after adjusting for age of onset, duration of epilepsy, and number of AEDs.

Conclusion Delayed treatment initiation is common in our sample and independently associated with poor seizure outcome.

 
  • References

  • 1 De Boer HM. “Out of the Shadows”: a global campaign against epilepsy. Epilepsia 43 suppl. (06) 2002; 7-8
  • 2 Meyer AC, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 88 2010; 260-266
  • 3 Placencia M, Shorvon SD, Paredes V. et al. Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain 115 1992; 771-782
  • 4 Nicoletti A, Sofia V, Vitale G. et al. Natural history and mortality of chronic epilepsy in an untreated population of rural Bolivia: a follow-up after 10 years. Epilepsia 50 2009; 2199-2206
  • 5 Zielihski JJ. Epileptics not in treatment. Epilepsia 15 1974; 203-210
  • 6 Berg AT, Shinnar S, Levy SR. et al. Two-year remission and subsequent relapse in children with newly diagnosed epilepsy. Epilepsia 42 2001; 1553-1562
  • 7 Sillanpaa M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med 338 1998; 1715-1722
  • 8 Abduljabbar M, Ogunniyi A, Daif AK, Al-Tahan A, Al-Bunyan M, Al-Rajeh S. Epilepsy classification and factors associated with control in Saudi adult patients. Seizure 7 1998; 501-504
  • 9 Lossius MI, Stavem K, Gjerstad L. Predictors for recurrence of epileptic seizures in a general epilepsy population. Seizure 8 1999; 476-479
  • 10 Sillanpaa M, Schmidt D, Sillanpaa M, Schmidt D. Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain 132 2009; 989-998
  • 11 Hauser WA, Lee JR, Hauser WA, Lee JR. Do seizures beget seizures. Prog Brain Res 135 2002; 215-219
  • 12 Camfield C, Camfield P, Gordon K, Dooley J. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy?. Not if the number is 10 or less. Neurology 46 1996; 41-44
  • 13 Shorvon SD, Reynolds EH. Early prognosis of epilepsy. BMJ (Clin Res Ed) 285 1982; 1699-1701
  • 14 Berg AT, Shinnar S. Do seizures beget seizures?. An assessment of the clinical evidence in humans. J Clin Neurophysiol 14 1997; 102-110
  • 15 Multani P, Myers RH, Blume HW, Schomer DL, Sotrel A. Neocortical dendritic pathology in human partial epilepsy: a quantitative golgi study. Epilepsia 35 1994; 728-736
  • 16 Kanemura H, Sano F, Tando T, Sugita K, Aihara M. Repeated seizures induce prefrontal growth disturbance in frontal lobe epilepsy. Brain Dev 34 2012; 175-180
  • 17 Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 1989; 389-399
  • 18 Devinsky O, Vickrey BG, Cramer JA. et al. Development of the quality of life in epilepsy inventory. Epilepsia 36 1995; 1089-1104
  • 19 Kwan P, Sander JW. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 75 2004; 1376-1381
  • 20 Feksi A, Kaamugisha J, Gatiti S, Sander J, Shorvon S. Comprehensive primary health care antiepileptic drug treatment in rural and semiurban Kenya. Lancet 337 1991; 406-409
  • 21 Placencia M, Sander JWAS, Shorvon SD. et al. Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12 month assessment. Epilepsy Res 14 1993; 237-244
  • 22 Watts A. The natural history of untreated epilepsy in a rural community in Africa. Epilepsia 33 1992; 464-468
  • 23 Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 13 2006; 277-282
  • 24 Del Felice A, Beghi E, Boero G. et al. Early versus late remission in a cohort of patients with newly diagnosed epilepsy. Epilepsia 51 2010; 37-42
  • 25 Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008 http://dx.doi.org/10.1111/j.1528-1167.2008.01693.x [PMID: 18557778]
  • 26 Liu RS, Lemieux L, Bell GS. et al. Progressive neocortical damage in epilepsy. Ann Neurol 53 2003; 312-324
  • 27 Wang PS, Angermeyer M, Borges G. et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6 2007; 177
  • 28 ten Have M, de Graaf R, van Dorsselaer S, Beekman A. Lifetime treatment contact and delay in treatment seeking after first onset of a mental disorder. Psychiatr Serv 64 2013; 981-989
  • 29 Uldall P, Alving J, Hansen LK, Kibæk M, Buchholt J. The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch Dis Child 91 2006; 219-221